VENUSREM
Start SIP
Invest Now
Start SIP in VENUSREM
Performance
- Low
- ₹783
- High
- ₹815
- 52 Week Low
- ₹270
- 52 Week High
- ₹840
- Open Price₹801
- Previous Close₹802
- Volume41,267
Investment Returns
- Over 1 Month + 16.35%
- Over 3 Month + 76.59%
- Over 6 Month + 81.22%
- Over 1 Year + 155.57%
Smart Investing Starts Here Start SIP with Venus Remedies for Steady Growth!
Venus Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 15
- PEG Ratio
- 0.1
- Market Cap Cr
- 1,053
- P/B Ratio
- 1.8
- Average True Range
- 40.99
- EPS
- 47.4
- Dividend Yield
- 0
- MACD Signal
- 53.51
- RSI
- 60.26
- MFI
- 52.41
Venus Remedies Financials
Venus Remedies Technicals
EMA & SMA
Current Price
₹788.05
-13.6
(-1.7%)
- Bearish Moving Average 3
- Bullish Moving Average 13
- 20 Day
- ₹758.91
- 50 Day
- ₹666.27
- 100 Day
- ₹583.41
- 200 Day
- ₹503.23
Resistance and Support
795.35
- R3 839.70
- R2 827.35
- R1 807.70
- S1 775.70
- S2 763.35
- S3 743.70
Venus Remedies Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-10 | Quarterly Results | |
| 2025-08-01 | Quarterly Results | |
| 2025-07-08 | Others | Inter-alia, to consider 1. Notice of 36th Annual General Meeting. 2. Boards Report for Financial Year 2024-2025. 3. Other business matters. |
| 2025-05-26 | Audited Results | |
| 2025-02-04 | Quarterly Results |
Venus Remedies F&O
About Venus Remedies
- NSE Symbol
- VENUSREM
- BSE Symbol
- 526953
- Chairman & Managing Director
- Mr. Pawan Chaudhary
- ISIN
- INE411B01019
Similar Stocks to Venus Remedies
Venus Remedies FAQs
Venus Remedies share price is ₹788 As on 26 December, 2025 | 23:22
The Market Cap of Venus Remedies is ₹1053.4 Cr As on 26 December, 2025 | 23:22
The P/E ratio of Venus Remedies is 15 As on 26 December, 2025 | 23:22
The PB ratio of Venus Remedies is 1.8 As on 26 December, 2025 | 23:22
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.